Moderna is applying for regulatory approval for its RSV vaccine, which it says has shown to be effective against the respiratory virus.
Share:
More In Science
Stretching Your Dollar: Navigating Insurance
Millions of people have selected insurance plans for 2024 but sometimes navigating them can be tricky time consuming and expensive. Paula Pant, host of 'Afford Anything' podcast, joined Cheddar News to break down what's needed to know about their insurance plans.
Study: Fast-Mimicking Diet Can Improve Hearth Health
A new study is shedding light on the benefits of the fast-mimicking diet and heart health.
Links Between Air Pollution and Dementia
A study published in the journal E-Clinical Medicine suggests there may be a link between air pollution and an increased risk of dementia and strokes.
First Oral Treatment for Postpartum Depression Available
A new pill is now available to treat postpartum depression.
Pine Species Thrives When Burnt, so Southerners Rekindle 'Fire Culture' to Boost Its Range
Prescribed burn associations are proving key to conservationists’ efforts to restore a longleaf pine range forming the backbone of forest ecology in the American Southeast.
Study: Insulin Surge After Meals Lowers Risk of Diabetes
A new study suggests higher blood sugar levels after eating could be a good thing.
CDC Urges Increased Vaccine Coverage
The Centers for Disease Control and Prevention announced an urgent need to increase vaccination coverage in response to rising respiratory disease levels.
W.H.O. Urges Ban on Flavored Vapes
The World Health Organization has warned that all E-cigarettes should be treated like tobacco and all flavored vapes should be banned.
Trial: Moderna, Merck Vaccine Reduces Cancer Death Rates
Merck and Moderna's cancer vaccine reduces the risk of death by about half, according to mid-stage trial data released Thursday.
